Johnson & Johnson (JNJ)

Pretax margin

Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Earnings before tax but after interest (EBT) US$ in thousands 16,687,000 36,889,000 21,725,000 22,776,000 16,497,000
Revenue US$ in thousands 88,607,000 84,021,000 79,428,000 93,356,000 82,174,000
Pretax margin 18.83% 43.90% 27.35% 24.40% 20.08%

December 31, 2024 calculation

Pretax margin = EBT ÷ Revenue
= $16,687,000K ÷ $88,607,000K
= 18.83%

To analyze Johnson & Johnson's pretax margin over the specified period, we observe a fluctuation in the ratio. The pretax margin, which represents the percentage of each dollar of revenue that translates into pre-tax income, increased from 20.08% in December 2020 to 24.40% in December 2021, indicating improved profitability. The trend continued positively as the pretax margin rose to 27.35% in December 2022 and significantly spiked to 43.90% by December 2023, suggesting a robust performance and effective cost management.

However, in December 2024, the pretax margin decreased to 18.83%, marking a decline from the previous year. This drop may be attributed to various factors such as increased operating expenses or changes in revenue streams. Overall, the analysis highlights the importance of monitoring pretax margin trends to assess a company's operational efficiency and financial performance.